Advertisement
Canada markets close in 4 hours 52 minutes

  • S&P/TSX

    21,942.24
    +56.86 (+0.26%)
     

  • S&P 500

    5,105.31
    +56.89 (+1.13%)
     

  • DOW

    38,211.66
    +125.86 (+0.33%)
     

  • CAD/USD

    0.7307
    -0.0016 (-0.22%)
     

  • CRUDE OIL

    83.65
    +0.08 (+0.10%)
     

  • Bitcoin CAD

    87,041.00
    +330.38 (+0.38%)
     

  • CMC Crypto 200

    1,330.39
    -66.15 (-4.74%)
     

  • GOLD FUTURES

    2,345.00
    +2.50 (+0.11%)
     

  • RUSSELL 2000

    1,996.79
    +15.67 (+0.79%)
     

  • 10-Yr Bond

    4.6570
    -0.0490 (-1.04%)
     

  • NASDAQ

    15,950.57
    +338.81 (+2.17%)
     

  • VOLATILITY

    15.35
    -0.02 (-0.13%)
     

  • FTSE

    8,138.87
    +60.01 (+0.74%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • CAD/EUR

    0.6838
    +0.0017 (+0.25%)
     
MARKETS LIVE BLOG:

STOCKS RISE, LED BY STELLAR ALPHABET, MICROSOFT EARNINGS

Results from 'Magnificent Seven' duo show cloud revenue boosted by strong AI demand

Compugen (CGEN) Worth a Look: Stock Adds 10.4% in Session

Zacks Equity Research
Updated

Compugen Ltd. CGEN was a big mover last session, as the company saw its shares rise over 10% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $3.65 to $4.30 in the past one-month time frame.

None of the estimates for this stock were revised in the last 30 days and the Zacks Consensus Estimate also remained unchanged. Friday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Currently, Compugen carries a Zacks Rank #4 (Sell).

Compugen Ltd. Price

 

Compugen Ltd. Price | Compugen Ltd. Quote

ADVERTISEMENT

A better-ranked stock in the same industry is Regeneron Pharmaceuticals, Inc. REGN, sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is CGEN going up? Or down? Predict to see what others think: Up or Down

Zacks' 2017 IPO Watch List

Before looking into the stocks mentioned above, you may want to get a head start on potential tech IPOs that are popping up on Zacks' radar. Imagine being in the first wave of investors to jump on a company with almost unlimited growth potential? This Special Report gives you the current scoop on 5 that may go public at any time. One has driven from 0 to a $68 billion valuation in 8 years. Four others are a little less obvious but already show jaw-dropping growth. Download this IPO Watch List today for free >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Click for Free Regeneron Pharmaceuticals, Inc. (REGN) Stock Analysis Report >>
 
Click for Free Compugen Ltd. (CGEN) Stock Analysis Report >>
 
To read this article on Zacks.com click here.
 
Zacks Investment Research